Cholesterol-Lowering Pitavastatin Tablet Gets USFDA Approval

by Madhumathi Palaniappan on  December 31, 2016 at 9:44 AM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The United States Food and Drug Administration (USFDA) has tentatively approved the cholesterol lowering Pitavastatin tablets from Lupin Pharmaceuticals.
Cholesterol-Lowering Pitavastatin Tablet Gets USFDA Approval
Cholesterol-Lowering Pitavastatin Tablet Gets USFDA Approval

"Pharma Major Lupin announced today that it has received tentative approval for its Pitavastatin tablets, 1 mg, 2 mg and 4 mg from the United States Food and Drug Administration (FDA) to market a generic version of Kowa Company Limited's (Kowa) Livalo Tablets 1 mg, 2 mg and 4 mg," the pharmaceutical company said in a regulatory filing to the BSE.

"Pitavastatin tablets are indicated as an adjunctive therapy to diet to reduce elevated total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia," it added.



Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive